Alpha-1 antitrypsin

NICE recommend considering a diagnosis of COPD in patients over 35 years of age who are smokers or ex-smokers and have symptoms such as exertional breathlessness, chronic cough or regular sputum production.

The following investigations are recommended in patients with suspected COPD:

The severity of COPD is categorised using the FEV1^^:

Post-bronchodilator FEV1/FVC FEV1 (of predicted) Severity
< 0.7 > 80% Stage 1 - Mild - symptoms should be present to diagnose COPD in these patients
< 0.7 50-79% Stage 2 - Moderate
< 0.7 30-49% Stage 3 - Severe
< 0.7 < 30% Stage 4 - Very severe

Measuring peak expiratory flow is of limited value in COPD, as it may underestimate the degree of airflow obstruction.

^^ note that the grading system has changed following the 2010 NICE guidelines. If the FEV1 is greater than 80% predicted but the post-bronchodilator FEV1/FVC is < 0.7 then this is classified as Stage 1 - mild

Management

Stable Management

Acute exacerbation of COPD

Acute exacerbations of COPD are one of the most common reasons why people present to hospital in developed countries.

The most common infective causes of COPD exacerbations are:

Features